Summary
Matthias Samwald is an initiative lead and associate professor with 13+ years at the intersection of AI and biomedicine, focused on how general-purpose AI can accelerate biomedical discovery and improve healthcare delivery. He combines deep technical knowledge of large language models and knowledge representation with practical experience deploying clinical decision support across seven European countries through the €15M U-PGx pharmacogenomics project. As co-chair of the EU General-Purpose AI Code of Practice drafting process, he bridges research, policy and risk assessment to promote responsible GPAI deployment. His background spans academia and applied research—ranging from postdoctoral work in personalized medicine to technology roles in research institutes—giving him a rare systems-level view of both scientific workflows and regulatory constraints. Based in Vienna, he is motivated by tangible health impact and by spotting subtle systemic risks, such as erosion of scientific evaluation processes, before they materialize.
13 years of coding experience
10 years of employment as a software developer
MSc, Neuroscience, Biology, Pharmacology, MSc, Neuroscience, Biology, Pharmacology at University of Vienna
Yale School of Medicine
Dr. rer. nat., Biomedical Informatics, Dr. rer. nat., Biomedical Informatics at Medical University of Vienna
English, German